Competences are provided by a multidisciplinary and highly interactive team made up of Professors and Researchers from different Departments of the University, with proven experience in both clinical and translational research in the cardiovascular, oncology and regenerative medicine. The staff of the Clinical Research Service also has consolidated experience in the study of the efficacy and safety of drugs, active compound and molecules of neo-synthesis on microorganisms (bacteria and fungi) with relevance for humans. The preclinical experimental activity is focused on the use of cell biology (cultures in 2D (monolayer) and 3D (spheroids and organoids) and molecular biology: PCR, Real-Time PCR, Digital Droplet PCR.
The Clinical Research Service offers a wide range of services related to the management of randomized and / or observational studies in the biomedical field together with biomarker analysis in biological samples from subjects involved in clinical study for correlation analysis with the clinical parameters in order to evaluate the response to a treatment or understand the molecular mechanisms underlying the studied pathologies. The Clinical Research service also conducts:
Thanks to the skills and technologies described above, the Clinical Research Service is able to offer the following services:
Computers and epidemiological / statistical software. Programs for the management of core labs in the electro, echo and coronary artery fields.
Droplet digital PCR.
Clinical Research
Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA)
"CUBO" Chemical Biomedical Pole Area - third floor
Via Fossato di Mortara 70 - 44121 Ferrara
+39 0532 242077
Prof. Gianluca Campo
cmpglc@unife.it
+39 0532 236450
Prof. Paola Rizzo
rzzpla@unife.it
+39 0532 242077
Prof. Fernanda Martini
Prof. Barbara Zavan
Prof. Elisabetta Caselli
Prof. Roberta Rizzo
Dott. Luisa Marracino
Arcangeletti MC, D’Accolti M, Maccari C, Soffritti I, De Conto F, Chezzi C, Calderaro A, Ferri C, Caselli E, (2020). Impact of human cytomegalovirus and human herpesvirus 6 infection on the expression of factors associated with cell fibrosis and apoptosis: clues for implication in systemic sclerosis development. International Journal of Molecular Sciences 21(17):6397. PubMed |
Bortolotti D, Gentili V, Rizzo S, Rotola A, Rizzo R, (2020) SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway. Cells 26;9(9):E1975. PubMed |
Caselli E, Fabbri C, D’Accolti M, Soffritti I, Bassi C, Mazzacane S, Franchi M, (2020). Defining the oral microbiome by Whole-Genome Sequencing and resistome analysis: the complexity of the healthy picture. BMC Microbiology 20:120. PubMed |
Gardin C, Ferroni L, Latremouille C, Chachques JC, Mitrečić D, Zavan B, (2020). Recent Applications of Three Dimensional Printing in Cardiovascular Medicine. Cells 9(3):742. PubMed |
Bortolotti D, Gentili V, Caselli E, Sicolo M, Soffritti I, D'Accolti M, Barao I, Rotola A, Di Luca D, Rizzo R, (2020) DNA Sensors' Signaling in NK Cells During HHV-6A, HHV-6B and HHV-7 Infection. Front Microbiol 11:226. PubMed |
Mazzoni E, D'Agostino A, Iaquinta M R, Bononi I, Trevisiol L, Rotondo J C, Patergnani S, Giorgi C, Gunson M J, Arnett G W, Nocini P F, Tognon M, Martini F., (2019) Hydroxylapatite‐collagen hybrid scaffold induces human adipose‐derived mesenchymal stem cells to osteogenic differentiation in vitro and bone regrowth in patients. Stem Cells Transl Med 9(3): 377–388. PubMed |
Iaquinta M R, Mazzoni E, Bononi I, Rotondo J C, Mazziotta C, Montesi M, Sprio S, Tampieri A, Tognon M, Martini F, (2019) Adult Stem Cells for Bone Regeneration and Repair. Front Cell Dev Biol 7:268. PubMed |
Cimaglia P, Vieceli Dalla Sega F, Vitali F, Lodolini V, Bernucci D, Passarini G, Fortini F, Marracino L, Aquila G, Rizzo P, Ferrari R, Campo G, (2019) Effectiveness of a Novel Nutraceutical Compound Containing Red Yeast Rice, Polymethoxyflavones and Antioxidants in the Modulation of Cholesterol Levels in Subjects With Hypercholesterolemia and Low-Moderate Cardiovascular Risk: The NIRVANA Study. Front Physiol 10: 217. PubMed |
Campo G, Vieceli Dalla Sega F, Pavasini R, Aquila G, Gallo F, Fortini F, Tonet E, Cimaglia P, Del Franco A, Pestelli G, Pecoraro A, Contoli M, Balla C, Biscaglia S, Rizzo P, Ferrari R, (2017) Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease. Thromb Haemost. 117(6): 1208-1216. PubMed |
Brunello G, Sivolella S, Meneghello R, Ferroni L, Gardin C, Piattelli A, Zavan B, Bressan E, (2016). Powder-based 3D printing for bone tissue engineering. Biotechnol Adv. 34(5):740-753. PubMed |
The Clinical Research Service has a rich network of collaborations in Italy and abroad. In particular, the Service is a constant and continuous collaborator of different Italian (Brescia, Udine, Verona, Salerno, Turin) and foreign Universities (Lousiana State University, Loyola University of Chicago and Harvard Medical School), public research Institutes, such as CNR of Faenza, Rizzoli IRCCS orthopedic institutes of Bologna, private health structures such as Maria Cecilia Hospital, GVM Care & Research, and companies operating in the ceramics field (Finceramica di Faenza), nutraceuticals (Incos, Castello d'Argile, Bologna), raw materials (HelixPharma srl), medical devices (FB Vision) and genomics (Genomix4life Srl). Among the collaborations abroad, the Clinical Research Service collaborates with the Almazov Cardiology Center in St. Petersburg, the Proteomics Center of the University of Utrecht, The Netherlands.
Code | Brief description of the service | Price (€ for hour or sample) |
RC-0C | Preliminary consulence for protocol formulation, experimental design and statistical analysis for clinical and observational studies; during the consulence, an estimate of the total cost of the required analyzes can be made. The Service offers consulence for specific projects, providing free estimates based on the user's needs. Please contact the referent for individual needs not specified in the tariff, as the packages offered can be modified as needed. For routine analysis the prices can be agreed (possible subscription). |
300.00 |
RC-01 | Market analysis | 170.00 |
RC-02 | Studies for possible clinical trials | 100.00 |
RC-03 | Process and review of documents for clinical trials | 130.00 |
RC-04 | Finalization of documents for clinical trials | 100.00 |
RC-05 | Regulatory activities in clinical trials | 110.00 |
RC-06 | Managing the opening of clinical trials | 90.00 |
RC-07 | Managing clinical trials at participating centers | 90.00 |
RC-08 | Monitoring clinical trials | 70.00 |
RC-09 | Project management | 110.00 |
RC-10 | Statistical evaluations and analysis | 120.00 |
RC-11 | Development and reporting management for the promoter/referent of the trial | 110.00 |
RC-BSL3-COV-0C | Preliminary consulence for the formulation of the experimental design of projects to be carried out in BSL3 with SARS-CoV-2; During the consulence, you will be able to estimate the overall cost of the required analyses. The Service offers consulence for specific projects, providing free quotes based on your needs Please contact the referent for individual needs not specified in the tariff, as the packages offered can be modified as needed. For routine analysis the prices can be agreed (possible subscription). |
Ask for quote |
RC-BSL3-COV-01 | Determining the antiviral activity of biological or chemical compounds (RUO) | Ask for quote |
RC-BSL3-COV-02 | Anti-Covid-19 activity Certification of biological or chemical compounds, according to standard procedures (UNI EN) | Ask for quote |
RC-BSL3-COV-03 | Production of cells infected with SARS-CoV-2 | 1000.00 |
RC-BSL3-COV-04 | Production of viral inoculation of infecting or non-infecting SARS-CoV-2 (raw) (0.5 ml) | 1000.00 |
RC-BSL3-COV-05 | Biological Titolation of SARS-CoV-2 on target cells (TCID50) | 1000.00 |
RC-BSL3-COV-06 | Detection of SARS-CoV-2 RNA in biological and environmental samples (Real time RT-PCR, CE-IVD) | 70.00/sample |
RC-BSL3-COV-07 | SARS-CoV-2 RNA title detection in biological and environmental samples (Real time RT-PCR, RUO) | 100.00/sample |
RC-BSL3-COV-08 | Analysis of soluble molecules (cytokines, chemokines, antibodies) using ELISA in biological samples contaminated with SARS-CoV-2 | Ask for quote |
RC-BSL3-COV-09 | Analysis of SARS-CoV-2 protein expression using fluorescence microscopy | 60.00 for sample |
RC-BSL3-COV-10 | Analysis of SARS-CoV-2 protein expression using immunohistochemistry | 60.00 for sample |
RC-BSL3-COV-11 | Analysis of the presence of Sars-CoV-2 by electron microscopy* | Ask for quote |
RC-BSL3-COV-12 | Decontamination of biological samples | 10.00 for sample |
RC-BSL3-COV-13 | Collection of biological samples | 1.00 for sample |
RC-BSL3-COV-14 | Fee to access to BSL3 | 20€/die |
RC-BSL3-COV-15 | Protein marker analysis - inhibition of cell genes involved in SARS-CoV-2 infection | 4,500.00 |
RC-BSL3-COV-16 | Nucleic acid analysis- inhibition of cell genes involved in SARS-CoV-2 infection | 4,500.00 |
RC-BSL3-COV-17 | Analysis of molecules that can prevent SARS-CoV-2 infection in human endothelial cells (use of pseudoviruses) | 4,500.00 |
Some services/products offered can take advantage of collaboration/integration with other services of the LTTA Laboratory.
*Electronic microscopy
Each service includes the description of the procedure and the supply of images for the purpose of any scientific publications.
Prices are to be understood without VAT and subject to update according to the tariffs of consumer products required for the service (each 12 months).